This was the stock's third consecutive day of losses.

Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare ...

Once a leading marijuana stock, the Canadian cannabis company has pivoted to craft beer and is trying to prevent being ...

Canada's legal cannabis market, valued at USD 3.25 Billion in 2024, is projected to reach USD 5.79 Billion by 2030, growing at a 12% CAGR. Key drivers include health benefits awareness, increasing ...

Once considered a darling of the cannabis sector, shares of Tilray Brands TLRY have steadily declined over the past few years ...

The stock's rise snapped a three-day losing streak.

Tilray Brands, Inc. TLRY shares are trading relatively flat in the premarket session on Wednesday. The firm has announced a product line expansion through its subsidiary, High Park Holdings Ltd., ...

Tilray has a proposed reverse stock split on the table that will help it avoid getting delisted from the Nasdaq. This move ...

Tilray Brands, a leader in the cannabis industry, recently announced a proposal to execute a reverse stock split. It hopes ...

Today's Forbes Daily newsletter covers a tariff on films produced abroad, AI startup hustle culture, an exclusive look at ...